NVCR - NovoCure - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart

NVCR is currently covered by 9 analysts with an average potential upside of $17.53 (31.18%) from yesterday's end of day stock price of $12.5. NovoCure activity chart has currently 84 price targets and 88 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 86.03% with an average time for these price targets to be met of 121 days.

Highest price target for NVCR is $119, Lowest price target is $20, average price target is $69.5.

Most recent stock forecast was given by EMILY BODNAR from HCWAINWRIGHT on 28-Aug-2023. First documented stock forecast 29-Jul-2016.

Currently, out of the existing stock ratings of NVCR - 4 which are a Sell (14.81%), 18 which are a Buy (66.67%), 5 which are a Hold (18.52%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

25

$8.85 (54.80%)

85

3 months 6 days ago

2/5 (40%)

$40.74 (88.94%)

152

Buy

45

$32.5 (260.00%)

62

3 months 26 days ago

14/22 (63.64%)

$32.67 (35.57%)

87

Hold

33

$20.5 (164.00%)

4 months 3 days ago

5/6 (83.33%)

$-15.49 (-14.57%)

128

Buy

95

$82.5 (660.00%)

5 months 28 days ago

2/4 (50%)

$42.96 (70.12%)

115

Hold

50

$33.85 (209.60%)

99

8 months 17 days ago

3/3 (100%)

$-6.7 (-8.42%)

42

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is NVCR (NovoCure) average time for price targets to be met?

On average it took 121 days on average for the stock forecasts to be realized with a an average price target met ratio 86.03

Which analyst has the current highest performing score on NVCR (NovoCure) with a proven track record?

GREGG GILBERT

Which analyst has the most public recommendations on NVCR (NovoCure)?

Gregg Gilbert works at BAML and has 10 price targets and 10 ratings on NVCR

Which analyst is the currently most bullish on NVCR (NovoCure)?

Difei Yang with highest potential upside - $187.5

Which analyst is the currently most reserved on NVCR (NovoCure)?

Larry Biegelsen with lowest potential downside - -$1

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart